retatrutide triple agonist glp-1 gip glucagon receptors Phase 3: 28.7% Weight Loss (2026) Retatrutide | GLP-1R/GIPR/GCGR ligand |

Gallbladder disorders: In the STEP 1 trial found a higher incidence of gallbladder-related events, such as gallstones or cholecystitis, was found in the semaglutide group than the placebo group

PMC 10772977

The supplemental approval was granted based on data from the Phase III EMBARK trial, which studied Xtandi plus leuprolide, placebo plus leuprolide (a synthetic hormone regulator) and Xtandi as a monotherapy

Its also crucial to follow the manufacturers recommendations on the product label while ashwagandha is generally considered safe, excessive intake may cause side effects such as vomiting or diarrhea

What Is Considered Normal

Anesth 105:521-33, 2006